Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bianca Grosser

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Cancer & Metabolism|July 11, 2024
The relationship between Stroma AReactive Invasion Front Areas (SARIFA), Warburg-subtype and survival: results from a large prospective series of colorectal cancer patientsKelly Offermans, Nic G Reitsam, Colinda C J M Simons, et al.
The American Journal of Surgical Pathology|May 9, 2025
Prognostic and Predictive Value of SARIFA-status Within Molecular Subgroups of Colorectal Cancer: Insights From the Netherlands Cohort StudyNic G Reitsam, Kelly Offermans, Colinda C J M Simons, et al.
The Journal of Pathology|September 28, 2021
Stroma AReactive Invasion Front Areas (SARIFA) - a new prognostic biomarker in gastric cancer related to tumor-promoting adipocytesBianca Grosser, Marie-Isabelle Glückstein, Christine Dhillon, et al.
Cancers|February 11, 2023
Alterations in Natural Killer Cells in Colorectal Cancer Patients with Stroma AReactive Invasion Front Areas (SARIFA)Nic G Reitsam, Bruno Märkl, Sebastian Dintner, et al.
Communications Medicine|August 15, 2024
Converging deep learning and human-observed tumor-adipocyte interaction as a biomarker in colorectal cancerNic G Reitsam, Bianca Grosser, David F Steiner, et al.
Cancers|July 8, 2020
Impact of Tumor Localization and Molecular Subtypes on the Prognostic and Predictive Significance of p53 Expression in Gastric CancerBianca Grosser, Meike Kohlruss, Julia Slotta-Huspenina, et al.
The Journal of Pathology. Clinical Research|January 31, 2022
Elevated microsatellite instability at selected tetranucleotide (EMAST) repeats in gastric cancer: a distinct microsatellite instability type with potential clinical impact?Anna-Lina Herz, Sarah Wisser, Meike Kohlruss, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 16, 2026
Tissue-Based Multiomic Exploratory Analysis of the uPa/uPAR System and Matrix Metalloproteinases in SARIFA-Positive Gastrointestinal CancersNic G Reitsam, Bianca Grosser, Sebastian Dintner, et al.
Langenbeck'S Archives of Surgery|July 9, 2026
Classifying the structural heterogeneity of peritoneal adhesions by histopathological extracellular matrix characteristicsMarcella Steffani, Jara Tigges, Zoé Clees, et al.
Cancers|October 13, 2021
Stroma AReactive Invasion Front Areas (SARIFA)-A New Easily to Determine Biomarker in Colon Cancer-Results of a Retrospective StudyBenedikt Martin, Bianca Grosser, Lana Kempkens, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Cancer & Metabolism|July 11, 2024
The relationship between Stroma AReactive Invasion Front Areas (SARIFA), Warburg-subtype and survival: results from a large prospective series of colorectal cancer patientsKelly Offermans, Nic G Reitsam, Colinda C J M Simons, et al.
The American Journal of Surgical Pathology|May 9, 2025
Prognostic and Predictive Value of SARIFA-status Within Molecular Subgroups of Colorectal Cancer: Insights From the Netherlands Cohort StudyNic G Reitsam, Kelly Offermans, Colinda C J M Simons, et al.
The Journal of Pathology|September 28, 2021
Stroma AReactive Invasion Front Areas (SARIFA) - a new prognostic biomarker in gastric cancer related to tumor-promoting adipocytesBianca Grosser, Marie-Isabelle Glückstein, Christine Dhillon, et al.
Cancers|February 11, 2023
Alterations in Natural Killer Cells in Colorectal Cancer Patients with Stroma AReactive Invasion Front Areas (SARIFA)Nic G Reitsam, Bruno Märkl, Sebastian Dintner, et al.
Communications Medicine|August 15, 2024
Converging deep learning and human-observed tumor-adipocyte interaction as a biomarker in colorectal cancerNic G Reitsam, Bianca Grosser, David F Steiner, et al.
Cancers|July 8, 2020
Impact of Tumor Localization and Molecular Subtypes on the Prognostic and Predictive Significance of p53 Expression in Gastric CancerBianca Grosser, Meike Kohlruss, Julia Slotta-Huspenina, et al.
The Journal of Pathology. Clinical Research|January 31, 2022
Elevated microsatellite instability at selected tetranucleotide (EMAST) repeats in gastric cancer: a distinct microsatellite instability type with potential clinical impact?Anna-Lina Herz, Sarah Wisser, Meike Kohlruss, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 16, 2026
Tissue-Based Multiomic Exploratory Analysis of the uPa/uPAR System and Matrix Metalloproteinases in SARIFA-Positive Gastrointestinal CancersNic G Reitsam, Bianca Grosser, Sebastian Dintner, et al.
Langenbeck'S Archives of Surgery|July 9, 2026
Classifying the structural heterogeneity of peritoneal adhesions by histopathological extracellular matrix characteristicsMarcella Steffani, Jara Tigges, Zoé Clees, et al.
Cancers|October 13, 2021
Stroma AReactive Invasion Front Areas (SARIFA)-A New Easily to Determine Biomarker in Colon Cancer-Results of a Retrospective StudyBenedikt Martin, Bianca Grosser, Lana Kempkens, et al.
Pageof 4